Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4540222
Max Phase: Preclinical
Molecular Formula: C35H44ClN5O5S
Molecular Weight: 645.83
Molecule Type: Unknown
Associated Items:
ID: ALA4540222
Max Phase: Preclinical
Molecular Formula: C35H44ClN5O5S
Molecular Weight: 645.83
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](N)C(=O)N[C@@H]1C(=O)N2[C@@H](CC[C@@H]1CNS(=O)(=O)c1ccc(C)cc1)CC[C@H]2C(=O)NC(c1ccccc1)c1ccccc1.Cl
Standard InChI: InChI=1S/C35H43N5O5S.ClH/c1-3-29(36)33(41)39-32-26(22-37-46(44,45)28-19-14-23(2)15-20-28)16-17-27-18-21-30(40(27)35(32)43)34(42)38-31(24-10-6-4-7-11-24)25-12-8-5-9-13-25;/h4-15,19-20,26-27,29-32,37H,3,16-18,21-22,36H2,1-2H3,(H,38,42)(H,39,41);1H/t26-,27+,29+,30+,32+;/m1./s1
Standard InChI Key: MJAJBVCIBXISQG-CYBMLNRPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 645.83 | Molecular Weight (Monoisotopic): 645.2985 | AlogP: 3.17 | #Rotatable Bonds: 11 |
Polar Surface Area: 150.70 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.39 | CX Basic pKa: 8.14 | CX LogP: 3.43 | CX LogD: 2.61 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.25 | Np Likeness Score: -0.56 |
1. (2013) SMAC mimetic compounds as apoptosis inducers, |
Source(1):